The loss of YTHDF1 in classic DCs can significantly enhance the cross‐presentation of tumor antigens and the cross‐activation of CD8+ T cells, which regulates durable neoantigen‐specific immunity.40 The gene discussed is CD8A; the disease is neoplasm.